Published in
Elsevier, Lung Cancer, (152), p. 109-118, 2021
DOI: 10.1016/j.lungcan.2020.12.026
Links
Tools
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors
Journal article published in 2020 by
B. Abbar 
,
V. De Castelbajac ,
P. Gougis ,
S. Assoun,
J. Pluvy ,
C. Tesmoingt,
N. Théou-Anton,
A. Cazes,
C. Namour,
A. Khalil,
V. Gounant,
B. Besse,
G. Zalcman ,
S. Brosseau
,
V. De Castelbajac ,
P. Gougis ,
S. Assoun,
J. Pluvy ,
C. Tesmoingt,
N. Théou-Anton,
A. Cazes,
C. Namour,
A. Khalil,
V. Gounant,
B. Besse,
G. Zalcman ,
S. Brosseau
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 